Drug manufacturer, Wockhardt has got final nod from the US Food and Drug Administration (USFDA) to sell Risperidone drug.

The source close to the company said that the proposed medicine will be available in 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg respectively.

Risperidone is used in Psychiatric Medicine to treat cases of Schizophrenia, a form of relatively permanent disorder of the mind.

Aurobindo Pharma has also received sanction for the same drug.

Earlier, On Sep.27, 2008, US Food and Drug Administration (USFDA) had given final approval to Wockhardt to manufacture and market Promethazine hydrochloride injection, in the strengths of 25 mg/ml and 50 mg/ml.

Stock of Wockhardt closed at Rs 153, up 5.33% on National Stock Exchange (NSE). The total volume of shares traded was 36,290 at the NSE.